Minnesota Senators Champion Landmark Legislation to Rein in Private Equity in Autism Therapy

St. Paul, MN – In a forceful response to a damning investigative report, two prominent Minnesota state senators are spearheading a legislative effort to impose stringent regulations on the burgeoning autism therapy sector, particularly targeting the pervasive influence of private equity investment firms. Citing a recent exposé by "The 74 Million," which revealed a disturbing pattern of unchecked profiteering and compromised patient care, State Senators Zaynab Mohamed (DFL-Minneapolis) and Scott Dibble (DFL-Minneapolis) announced their intent to introduce bills demanding greater transparency and accountability from providers.

The proposed legislation comes at a critical juncture, as the nation grapples with the escalating costs of specialized healthcare and the ethical implications of commodifying care for vulnerable populations. Minnesota, known for its commitment to accessible services for disabled children, has become a prime target for these investment firms, making the state a crucial battleground in the fight to prioritize patient well-being over corporate profits.

"This report is outrageous," declared Senator Mohamed, her voice reflecting widespread indignation. "The idea that Wall Street investors are exploiting these programs for profit is infuriating. Our children’s health and development should never be a vehicle for private gain." Her sentiments underscore a growing unease among policymakers and patient advocates about the true cost of unregulated capital in the healthcare landscape.

The Unsettling Findings: Private Equity’s Grip on Autism Therapy

The impetus for Minnesota’s legislative push stems directly from "The 74 Million’s" comprehensive investigation, which meticulously documented how private equity firms have infiltrated and reshaped the autism therapy industry over the past decade. These firms, operating with minimal oversight, have systematically acquired hundreds of independently run "mom-and-pop" therapy centers across the nation, consolidating them into lucrative, expansive networks. This aggressive consolidation has fundamentally altered the financial dynamics of a sector critical to thousands of families.

The Rise of Private Equity in Applied Behavior Analysis (ABA)

The investigation revealed a staggering escalation in Medicaid reimbursements for Applied Behavior Analysis (ABA) – the dominant treatment modality for autism. From a substantial $400 million in 2019, nationwide Medicaid reimbursements for ABA therapy skyrocketed to nearly $2 billion by 2024. This five-fold increase in just five years signals an unprecedented boom, heavily fueled by the entry of private equity.

A granular analysis of U.S. Centers for Medicare and Medicaid records by "The 74 Million" painted an even starker picture. It found that private equity firms now own almost half of the 50 companies with the highest claims, collectively accounting for a staggering $3.1 billion of the nearly $7 billion billed over the investigation’s six-year scope. These figures lay bare the immense financial leverage and market dominance wielded by these investment entities.

Critiques of Applied Behavior Analysis and Its Efficacy

Beyond the financial implications, "The 74 Million’s" reporting also critically examined the very foundation of ABA therapy itself. Building on prior investigative work, the report highlighted the "weak evidence base" supporting ABA, a behavioral conditioning treatment often administered to autistic children as young as two, for up to 40 hours a week. Designed to "extinguish" autistic traits through a system of rewards and punishments, ABA has become the de facto standard for autism services across the country.

However, a growing body of recent research challenges this dominance, revealing troubling findings regarding its long-term impact on patients. Studies have indicated heightened rates of Post-Traumatic Stress Disorder (PTSD) and psychiatric hospitalizations among individuals who underwent the intensive intervention. This raises profound ethical questions about a therapy that, while widely reimbursed, may be causing significant mental health distress in its recipients. The ethical debate around neurodiversity, which advocates for embracing autistic traits rather than attempting to eliminate them, further complicates the picture, suggesting that the drive for profit may be overshadowing evolving understandings of autism and patient-centered care.

The "Attractive Market" of Minnesota

As private equity firms increasingly sought higher returns, they demonstrated a clear pattern of divesting from states with lower Medicaid reimbursement rates and aggressively expanding into those with more generous benefits. Minnesota, alongside a handful of other states that have proactively sought to make services accessible to as many families with disabled children as possible, inadvertently became an "attractive market" for these large, for-profit providers. This influx, while seemingly expanding access, has also brought with it the systemic vulnerabilities associated with profit-driven healthcare.

Legislative Push for Accountability: Minnesota’s Response

In the face of these revelations, Senators Mohamed and Dibble are moving swiftly to introduce legislation aimed at rectifying the imbalances and protecting Minnesota’s most vulnerable residents. Their proposed reforms center on two critical pillars: transparency of ownership and the power to regulate business models that compromise care.

Demanding Transparency and Ethical Oversight

At the heart of their legislative agenda is a mandate for transparent reporting of who owns autism services centers. This addresses a critical information asymmetry that currently allows private equity firms to operate with opaque ownership structures, making it exceedingly difficult to trace accountability when patient care suffers.

"It’s not enough to have a P.O. box in New Jersey," asserted Senator Dibble, drawing a stark comparison to other regulated industries. "I think we’re entitled to know – this particular entity, what else do they own, and how well have they provided services? Before someone can come in and purchase a liquor license, they need to prove that they’re an outstanding citizen who hasn’t participated in any shady practices and they can be entrusted with the public trust that a publicly issued license entails. The care of vulnerable children should demand no less scrutiny."

Beyond mere disclosure, the senators seek to empower the state to "weed out" those providers whose profit-driven business models demonstrably compromise the quality of children’s care. This proactive regulatory power is intended to prevent the systemic issues observed in other healthcare sectors from taking deeper root in autism therapy.

Prioritizing Patient Care Over Profit Margins

A key component of the proposed legislation would also require providers to dedicate a certain percentage of the Medicaid reimbursements they receive directly to patient care. This measure aims to curb excessive administrative costs, inflated executive salaries, and dividend payouts that divert funds away from the direct services intended for autistic children.

"This kind of aggressive, super-sized profit motive is totally inappropriate in these settings because it incentivizes behaviors that don’t support the public’s interest and good use of public dollars," Dibble explained, highlighting the fundamental conflict between maximizing shareholder returns and delivering high-quality, ethical healthcare. This requirement would ensure that public funds, earmarked for a critical service, are primarily utilized for their intended purpose.

The senators also emphasized the urgency of their reforms in light of broader legislative changes, specifically mentioning the "One Big Beautiful Bill Act," which is expected to slash Medicaid spending. As state resources tighten, they argue, it becomes even more imperative for states to find innovative ways to sustain children’s benefits and ensure that every dollar is spent efficiently and ethically.

The Broader Landscape: Private Equity’s Impact on Healthcare

The situation in Minnesota’s autism therapy sector is not an isolated incident but rather a microcosm of a larger, systemic issue plaguing the American healthcare system: the growing penetration of private equity into traditionally public or non-profit service areas. Senator Dibble, with his previous legislative experience, is acutely aware of these parallels.

Lessons from Long-Term Care

Last year, Dibble authored a bill mandating the disclosure of ownership for nursing homes and assisted living facilities acquired by for-profit companies. While that bill ultimately did not pass into law, the rationale behind it remains acutely relevant. A recent investigation by state healthcare monitors in Minnesota found that a staggering 79% of complaints regarding abuse and neglect in long-term care facilities investigated by the Minnesota Department of Health involved for-profit companies. This statistic provides a chilling precedent for what can happen when profit motives supersede patient welfare in vulnerable care settings.

Dibble and other critics contend that when patient care suffers as a result of such business models, the lack of clarity regarding a company’s true ownership makes it virtually impossible to hold anyone accountable. Private equity firms typically acquire privately held companies with access to steady revenue streams, extract as much cash as possible in the short term, often through leveraged buyouts, and then leave behind a mountain of debt when investors decide to move on.

The Cycle of Exploitation and Abandonment

The impact of this "acquire, leverage, extract, divest" cycle on applied behavior analysis mirrors the devastating consequences observed in other healthcare industries. When private equity firms have paid out their investors and exited the market, the remaining debt frequently leaves the healthcare providers bankrupt or severely crippled, unable to continue offering essential services. In the context of autism therapy, this means families are often left scrambling to find new providers, disrupting critical ongoing care for their children. The emotional and financial toll on these families can be immense, highlighting the deep instability introduced by such investment strategies.

Federal Scrutiny and Systemic Problems

The issue of Medicaid waste and fraud has garnered significant attention, even at the federal level. Last winter, the Trump administration justified a controversial Immigration and Customs Enforcement incursion into the Twin Cities, claiming it was necessary to root out Medicaid abuse perpetrated by immigrants. While that action drew widespread criticism, a different perspective emerged from the Department of Government Efficiency, which in February released a massive 275 million-record Medicaid dataset. The stated goal was to identify waste, fraud, and abuse. However, "The 74 Million’s" analysis of this very data revealed a distinct and far more pervasive systemic problem: unchecked profiteering and lax state and federal oversight of ABA, driven largely by the rapid acquisition of its providers by private equity. This shift in focus from individual "fraudsters" to systemic corporate exploitation underscores the urgent need for structural reforms.

Implications and the Path Forward

The legislative initiative by Senators Mohamed and Dibble represents a crucial step towards reasserting public interest and ethical governance in a vital healthcare sector. The implications of their proposed reforms extend far beyond Minnesota’s borders.

Ethical Dilemmas and Vulnerable Populations

At its core, this legislative push confronts the profound ethical dilemma of allowing the care of highly vulnerable populations, such as autistic children, to be dictated by profit motives. When financial returns become the primary driver, there is an inherent risk that the quality, appropriateness, and patient-centeredness of care will be compromised. The concerns around ABA’s efficacy and potential for harm, coupled with the business practices of private equity, demand a re-evaluation of current standards and oversight mechanisms. The goal should be to foster an environment where therapy truly benefits the child, rather than enriching investors.

Setting a National Precedent

If successful, Minnesota’s legislation could serve as a powerful model for other states grappling with similar challenges. The lack of federal oversight in this area means that state-level initiatives are critical to establishing new norms for transparency and accountability in healthcare. By demonstrating how to effectively regulate private equity’s influence, Minnesota could pave the way for a broader national movement to protect patients from the adverse effects of unchecked financialization in healthcare.

The Challenge of Robust Oversight

Implementing robust oversight will not be without its challenges. Private equity structures are notoriously complex, often involving intricate networks of holding companies and offshore entities designed to obscure ownership and limit liability. Regulators will need sophisticated tools and expertise to effectively penetrate these structures and enforce compliance. However, the senators’ determination signals a clear commitment to overcoming these obstacles.

The fight to reform autism therapy and curb the influence of private equity is a battle for the integrity of healthcare itself. Minnesota’s legislative leaders are sending a clear message: the health and well-being of children must always take precedence over the pursuit of profit. The outcome of their efforts will not only shape the future of autism care in the state but could also set a vital precedent for how society protects its most vulnerable in an increasingly commodified world.